risankizumab,tofacitinib,vedolizumab,azacitidine,ustekinumab,ozanimod,upadacitinib,adalimumab,golimumab,infliximab
abbvie,bms,janssen,takeda,pfizer
['ibd', ' uc ']
 putting it all together with this slide in #aibd2022: positioning of advanced therapies. 
Gastroenterologist & epidemiologist. Professor @UCalgary. Associate Editor, @AGA_Gastro Article is my life's work: https://t.co/2Y2gG6Gel4 Tweets are personal